New medicines that spur weight loss and handle diabetes have been using the public—and the pharmaceutical marketplace—by storm. The newest entrant, Zepbound, recently joined Ozempic, Wegovy, Victoza and Some others inside of a increasing course of prescription drugs known as GLP-one receptor agonists.In this article’s what you have to know ab